A poll of Massachusetts residents by Harvard’s School of Public Health and the Blue Cross Blue Shield of Massachusetts Foundation found that regular people in Massachusetts are remarkably well informed about the primary reasons their health care is so extremely expensive compared to health care in other industrialized countries. According to the poll regular people [...]

Looking at how the incentives in our health care market are currently set up, there is little reason to hope the “market” will magically come up with innovations to reduce our national health care spending. It is no surprise given looking at our structural innovation issues that for decades we have seen health care cost grow so rapidly.

There are many legitimate diverging opinions about the quality of the new health care reform law, what shouldn’t be in dispute is the well-documented fact that it was a corporate sellout, or at least contained several large very specific sellouts to large corporate interests. Yet David Leonhardt, who must have been hiding under a rock [...]

Anna Eshoo (D-PhRMA) may be the author of the language granting drug companies endless monopolies on biologic drugs, but she couldn’t have done it without the help of her good friend Jane Harman.  A new letter from the Winograd campaign says: The latest health insurance reform bill includes an amendment, supported by Jane Harman, member [...]